After infecting the corresponding tumor-bearing mice intravenously, the immune system successfully recognized tumor-specific antigens while mounting immune responses against Plasmodium. This process significantly promoted specific CD8+ T cell responses against tumor cells, thus inhibiting cancer progression. This evidence concerns the gene CD8A and neoplasm.